ArticleAddiction (Abingdon, England)2019
Prevalence of awareness, ever-use and current use of nicotine vaping products (NVPs) among adult current smokers and ex-smokers in 14 countries with differing regulations on sales and marketing of NVPs: cross-sectional findings from the ITC Project.
Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04982978 (The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population
Who cites it
47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 86 citations in OpenAlex.
- Prevalence and determinants of e-cigarette use in South Asia: a systematic review.BMJ global health · 2025Pooled it
- Prevalence and Associated Factors of E-Cigarette Use among Adolescents in Southeast Asia: A Systematic Review.International journal of environmental research and public health · 2023Pooled it
- Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis.The Lancet. Public health · 2021Pooled it
- Prevalence and Associated Factors of Tobacco Use Among the Indigenous Population in Peninsular Malaysia.Journal of community health · 2026Article
- Knowledge and attitudes toward e-cigarette smoking among health and non-health science students: A cross-sectional study.Tobacco prevention & cessation · 2026Article
- A scoping review and thematic analysis of policy implications of novel and emerging nicotine and tobacco products regulation.Frontiers in public health · 2026Article
- Cigarette smoking, e-cigarette, and heated tobacco product use and associated factors among a nationally representative sample of adult Malaysians: An online survey.Tobacco induced diseases · 2026Article
- The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Article
- Article
- Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025Article
- To use or not to use electronic cigarettes? Reasons for use, stopping use and their behavioural sequelae among Mexicans who smoke.Tobacco control · 2024Article
- The potential impact of removing a ban on electronic nicotine delivery systems using the Mexico smoking and vaping model (SAVM).medRxiv : the preprint server for health sciences · 2024Article
- Decisions of the FDA on premarket tobacco product applications: Changes in the number of unique devices and liquids used by US adults who frequently use electronic nicotine delivery systems, 2020-2023.Tobacco induced diseases · 2024Article
- Prevalence, lived experiences and user profiles in e-cigarette use: A mixed methods study among French college students.PloS one · 2024Article
- Associations between vaping and daily cigarette consumption among individuals with psychological distress.Tobacco prevention & cessation · 2024Article
- Pattern and prevalence of vaping nicotine and non-nicotine drugs in the United Kingdom: a cross-sectional study.BMJ open · 2023Article
- Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity.Harm reduction journal · 2023Article
- Do Social Norms for Cigarette Smoking and Nicotine Vaping Product Use Predict Trying Nicotine Vaping Products and Attempts to Quit Cigarette Smoking Amongst Adult Smokers? Findings From the 2016-2020 International Tobacco Control Four Country Smoking and Vaping Surveys.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Knowledge and Attitude toward E-Cigarettes among First Year University Students in Riyadh, Saudi Arabia.Healthcare (Basel, Switzerland) · 2023Article
- Factors Associated with Knowledge and Attitude towards E-Cigarettes among Undergraduate Students in Thailand: A Cross-Sectional Study.Asian Pacific journal of cancer prevention : APJCP · 2023Article
Corrections and comments
- Commented on by
Authors and funding
25 authors at 18 institutions in 14 countries.
Funding
Abstract
aimsThis paper presents updated prevalence estimates of awareness, ever-use, and current use of nicotine vaping products (NVPs) from 14 International Tobacco Control Policy Evaluation Project (ITC Project) countries that have varying regulations governing NVP sales and marketing. DESIGN, SETTING, PARTICIPANTS AND MEASUREMENTS: A cross-sectional analysis of adult (≥ 18 years) current smokers and ex-smokers from 14 countries participating in the ITC Project. Data from the most recent survey questionnaire for each country were included, which spanned the period 2013-17. Countries were categorized into four groups based on regulations governing NVP sales and marketing (allowable or not), and level of enforcement (strict or weak where NVPs are not permitted to be sold): (1) most restrictive policies (MRPs), not legal to be sold or marketed with strict enforcement: Australia, Brazil, Uruguay; (2) restrictive policies (RPs), not approved for sale or marketing with weak enforcement: Canada, Malaysia, Mexico, New Zealand; (3) less restrictive policies (LRPs), legal to be sold and marketed with regulations: England, the Netherlands, Republic of Korea, United States; and (4) no regulatory policies (NRPs), Bangladesh, China, Zambia. Countries were also grouped by World Bank Income Classifications. Country-specific weighted logistic regression models estimated adjusted NVP prevalence estimates for: awareness, ever/current use, and frequency of use (daily versus non-daily).
findingsNVP awareness and use were lowest in NRP countries. Generally, ever- and current use of NVPs were lower in MRP countries (ever-use = 7.1-48.9%; current use = 0.3-3.5%) relative to LRP countries (ever-use = 38.9-66.6%; current use = 5.5-17.2%) and RP countries (ever-use = 10.0-62.4%; current use = 1.4-15.5%). NVP use was highest among high-income countries, followed by upper-middle-income countries, and then by lower-middle-income countries.
conclusionsWith a few exceptions, awareness and use of nicotine vaping products varied by the strength of national regulations governing nicotine vaping product sales/marketing, and by country income. In countries with no regulatory policies, use rates were very low, suggesting that there was little availability, marketing and/or interest in nicotine vaping products in these countries where smoking populations are predominantly poorer. The higher awareness and use of nicotine vaping products in high income countries with moderately (e.g. Canada, New Zealand) and less (e.g. England, United States) restrictive policies, is likely due to the greater availability and affordability of nicotine vaping products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.